Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 601 22 516.3 |
96 | EP file number | EAKZ | 01 93 4967.9 |
86 | WO file number | WAKZ | PCT/US01/13998 |
97 | EP publication number | EPN | 1292612 |
87 | WO publication number | WPN | 2001098328 |
54 | Designation/title | TI | PHOSPHONATDERIVATE EINES GLYKOPEPTIDES |
51 | IPC main class | ICM (ICMV) | C07K 9/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 38/14 (2006.01), A61P 31/04 (2006.01) |
22 | DE application date | DAT | May 1, 2001 |
96 | EP application date | EAT | May 1, 2001 |
86 | WO application date | WAT | May 1, 2001 |
43 | Date of first publication | OT | Dec 27, 2001 |
| Date of publication of grant | PET | Aug 23, 2006 |
71/73 | Applicant/owner | INH | Cumberland Pharmaceuticals Inc., Nashville, Tenn., US |
72 | Inventor | IN | LEADBETTER R., Michael, San Leandro, CA 94577, US; LINSELL S., Martin, San Mateo, CA 94402, US |
74 | Representative | VTR | Abitz & Partner Patentanwälte mbB, 81925 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000060122516T2 Searchable text:
DE000060122516T2 |
| Address for service | | Abitz & Partner Patentanwälte mbB, 81628 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 213410 P Jun 22, 2000
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2011 100 062.5 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
81 | Designated WO countries | WDS | LT, SI, AL, LV, MK, RO |
| Published EP/WO documents | EPWOPN | Original document:
EP000001292612 Searchable text:
EP000001292612 Original document:
EP000001292612B1 Searchable text:
EP000001292612B1 Original document:
WO002001098328 Searchable text:
WO002001098328 |
43 | Date of first publication | EVT | Dec 27, 2001 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | May 4, 2021 (Show all update days)(Hide all update days)- May 4, 2021; Apr 28, 2020; Nov 6, 2019; Aug 16, 2019; Apr 25, 2019; Apr 4, 2019; Feb 28, 2019; Feb 15, 2019; Oct 29, 2018; Jun 14, 2018; Jun 12, 2018; Jun 13, 2017; Jun 9, 2017; Jun 15, 2016; Jun 9, 2016; Dec 3, 2015; Jun 13, 2015; Dec 31, 2014; Nov 26, 2014; Jun 20, 2014; Jun 12, 2014; Aug 2, 2013; Jun 15, 2013; Jun 11, 2013; Jan 24, 2013
- Historical data not available for this/these date(s)
- Sep 30, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 27, 2006 |
| Issue number | HN | 53 |
| Year | PJ | 2014 |
| Publication date | VT | Dec 31, 2014 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | Theravance, Inc., South San Francisco, Calif., US |
71/73 | Previous applicant/owner | INHF | Advanced Medicine, Inc., South San Francisco, Calif., US, Leadbetter, Michael R., San Leandro, Calif., US, Linsell, Martin S., San Mateo, CA |